DexCom, Inc. (DXCM)
81.39
+1.04
(+1.30%)
USD |
NASDAQ |
Nov 12, 16:00
81.39
0.00 (0.00%)
After-Hours: 20:00
DexCom Enterprise Value : 29.93B for Nov. 12, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 29.93B |
| November 11, 2026 | 29.54B |
| November 10, 2026 | 29.39B |
| November 09, 2026 | 29.81B |
| November 06, 2026 | 29.19B |
| November 05, 2026 | 31.08B |
| November 04, 2026 | 32.58B |
| November 03, 2026 | 30.52B |
| November 02, 2026 | 31.19B |
| October 30, 2026 | 30.27B |
| October 29, 2026 | 29.39B |
| October 28, 2026 | 28.90B |
| October 27, 2026 | 28.88B |
| October 26, 2026 | 28.88B |
| October 23, 2026 | 28.65B |
| October 22, 2026 | 28.79B |
| October 21, 2026 | 29.51B |
| October 20, 2026 | 31.56B |
| October 19, 2026 | 31.65B |
| October 16, 2026 | 31.67B |
| October 15, 2026 | 32.29B |
| October 14, 2026 | 30.71B |
| October 13, 2026 | 31.30B |
| October 12, 2026 | 31.62B |
| October 09, 2026 | 30.95B |
| Date | Value |
|---|---|
| October 08, 2026 | 31.06B |
| October 07, 2026 | 31.02B |
| October 06, 2026 | 30.68B |
| October 05, 2026 | 31.99B |
| October 02, 2026 | 31.41B |
| October 01, 2026 | 31.74B |
| September 30, 2026 | 31.76B |
| September 29, 2026 | 32.15B |
| September 28, 2026 | 32.16B |
| September 25, 2026 | 32.14B |
| September 24, 2026 | 32.46B |
| September 23, 2026 | 32.56B |
| September 22, 2026 | 33.24B |
| September 21, 2026 | 33.10B |
| September 18, 2026 | 33.17B |
| September 17, 2026 | 32.64B |
| September 16, 2026 | 32.41B |
| September 15, 2026 | 32.08B |
| September 14, 2026 | 31.41B |
| September 11, 2026 | 30.79B |
| September 10, 2026 | 31.35B |
| September 09, 2026 | 31.11B |
| September 08, 2026 | 31.35B |
| September 04, 2026 | 32.62B |
| September 03, 2026 | 33.31B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 213.21B |
| Globus Medical, Inc. | 9.182B |
| Baxter International, Inc. | 19.33B |
| Becton, Dickinson & Co. | 74.08B |
| Intuitive Surgical, Inc. | 148.53B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 275.10M |
| Revenue (Quarterly) | 1.344B |
| Total Expenses (Quarterly) | 1.069B |
| EPS Diluted (Quarterly) | 0.7215 |
| Gross Profit Margin (Quarterly) | 64.29% |
| Profit Margin (Quarterly) | 20.46% |
| Earnings Yield | 3.13% |
| Operating Earnings Yield | 3.84% |
| Normalized Earnings Yield | 3.135 |